Publications by authors named "Barbara Alemar"

Claim this Profile
C
Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
Tiago Finger Andreis, Kayana Isabel Weber de Souza, Igor Araujo Vieira, Bárbara Alemar, Marialva Sinigaglia

Gene· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
Camila Matzenbacher Bittar, Yasminne Marinho de Araújo Rocha, Igor Araujo Vieira, Clévia Rosset, Tiago Finger Andreis, Barbara Alemar

PLoS One· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America.
Josef S Herzog, Yanin Chavarri-Guerra, Danielle Castillo, Julio Abugattas, Cynthia Villarreal-Garza, Bárbara Alemar

NPJ Breast Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
Pier Selenica, Barbara Alemar, Cathleen Matrai, Karen L Talia, Emanuela Veras

Mod Pathol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.
Nicholas Olson, Rodrigo Gularte-Mérida, Pier Selenica, Arnaud Da Cruz Paula, Barbara Alemar

Int J Surg Pathol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Calcium Signaling Alterations Caused by Epigenetic Mechanisms in Pancreatic Cancer: From Early Markers to Prognostic Impact.
Cleandra Gregório, Sheila Coelho Soares-Lima, Bárbara Alemar, Mariana Recamonde-Mendoza, Diego Camuzi

Cancers (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haplotypic characterization of BRCA1 c.5266dupC, the prevailing mutation in Brazilian hereditary breast/ovarian cancer.
Renan Gomes, Barbara Luisa Soares, Paula Silva Felicio, Rodrigo Michelli, Cristina B O Netto, Barbara Alemar

Genet Mol Biol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 variants of uncertain significance: increasing challenges in variant interpretation and genetic counseling.
Camila Matzenbacher Bittar, Igor Araujo Vieira, Cristina Silva Sabato, Tiago Finger Andreis, Bárbara Alemar

Fam Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massively parallel sequencing analysis of benign melanocytic naevi.
John R Lozada, Felipe C Geyer, Pier Selenica, David Brown, Barbara Alemar

Histopathology· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era.
Gabriel S Macedo, Barbara Alemar, Patricia Ashton-Prolla

Genet Mol Biol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of a monoclonal antibody 11C8B1 as a diagnostic marker of IDH2-mutated sinonasal undifferentiated carcinoma.
Snjezana Dogan, Denise Frosina, Miriam Fayad, Thais Basili de Oliveira, Barbara Alemar

Mod Pathol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and characterization of BRCA2 c.156_157insAlu in Brazil: Results from 1380 individuals from the South and Southeast.
Paula Silva Felicio, Barbara Alemar, Aline Silva Coelho, Gustavo Noriz Berardinelli, Matias Eliseo Melendez

Cancer Genet· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.
John R Lozada, Thais Basili, Fresia Pareja, Barbara Alemar, Arnaud Da Cruz Paula

Histopathology· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.
Fresia Pareja, Alissa H Brandes, Thais Basili, Pier Selenica, Felipe C Geyer, Barbara Alemar

Nat Commun· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The germline mutational landscape of BRCA1 and BRCA2 in Brazil.
Edenir Inêz Palmero, Dirce Maria Carraro, Barbara Alemar, Miguel Angelo Martins Moreira, Ândrea Ribeiro-Dos-Santos

Sci Rep· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto

PLoS One· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53 signaling pathway polymorphisms, cancer risk and tumor phenotype in TP53 R337H mutation carriers.
Gabriel S Macedo, Igor Araujo Vieira, Fernanda Salles Luiz Vianna, Barbara Alemar, Juliana Giacomazzi

Fam Cancer· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Bárbara Alemar, Cleandra Gregório, Josef Herzog, Camila Matzenbacher Bittar, Cristina Brinckmann Oliveira Netto

PLoS One· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
Bárbara Alemar, Josef Herzog, Cristina Brinckmann Oliveira Netto, Osvaldo Artigalás, Ida Vanessa D Schwartz

Cancer Genet· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary regarding Schayek et al., entitled "The rate of recurrent BRCA1, BRCA2, and TP53 mutations in the general population, and unselected ovarian cancer cases, in Belo Horizonte, Brazil".
Fernanda Sales Luiz Vianna, Barbara Alemar, Maria Isabel Achatz, Suzi Alves Camey, Patricia Ashton-Prolla

Cancer Genet· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.
Edenir Inêz Palmero, Bárbara Alemar, Lavínia Schüler-Faccini, Pierre Hainaut, Carlos Alberto Moreira-Filho

Genet Mol Biol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Bárbara Alemar, Patrícia Izetti, Cleandra Gregório, Gabriel S Macedo, Mauro Antonio Alves Castro

Pancreas· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review.
Bárbara Alemar, Cleandra Gregório, Patricia Ashton-Prolla

Biomark Insights· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines.
Patricia Izetti, Agnes Hautefeuille, Ana Lucia Abujamra, Caroline Brunetto de Farias, Juliana Giacomazzi, Bárbara Alemar

Invest New Drugs· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Juliana Giacomazzi, Simone G Selistre, Cristina Rossi, Barbara Alemar, Patricia Santos-Silva

Cancer· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis